+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-05-08Number of Pages: 192

Hematopoietic Stem Cell Transplantation (HSCT) Market (Transplant Type - Allogeneic (Family Related and Unrelated) and Autologous; Disease Indication - Lymphoproliferative Disorders, Leukemia, and Non-Malignant Disorders; Application - Peripheral Blood Stem Cells Transplant (PBSCT), Bone Marrow Transplant (BMT), and Cord Blood Transplant (CBT)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Snapshot

The global market hematopoietic stem cell transplantation (HSCT) has been witnessing a high rise in its valuation and size over the last few years and is anticipated to remain doing so over the next few years. The considerable rise in the geriatric population and the increasing prevalence of non-communicable diseases is the key driving force behind the growth of this market. The increasing life expectancy, growing income, and the escalating government expenditure on health care, free trade agreement, and continuous research and development are other prominent factors, boosting the demand for HSCT across the world.

Over the coming years, the worldwide HSCT market is expected to gain substantially from the continual research and development to provide innovative drugs and treatment for a host of diseases. In terms of opportunity, the market is estimated to increase at a CAGR of 12.80% from 2017 to 2025, rising from a value of US$13.06 bn in 2016 to US$37.61 bn by the end of 2025.

hematopoietic stem cells transplantation market

Europe to Continue Leading Global Hematopoietic Stem Cell Transplantation (HSCT) Market

On the basis of geography, the global hematopoietic stem cell transplantation market is classified into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Among these, Europe and North America have been leading the global market with a large population size, increase in health expenditure, and the presence of a state-of-art medical and healthcare infrastructure. Europe holds the dominant position in the global market and is anticipated to remain on the top over the next few years on account of the rising prevalence of hematological as well as non-hematological disorders.

The second position in the global HSCT market has been acquired by North America. The presence of a well-established medical and healthcare industry, increasing investments for research and development, introduction of improved and technologically advanced hematopoietic stem cells transplantation services on regular intervals, and the high gross domestic product (GDP) of countries in this region are some of the key factors behind the rise of the North America HSCT market.

Allogeneic Transplants to Dominate Global Market

Based on the type of transplant, the worldwide market for hematopoietic stem cell transplantation (HSCT) has been categorized into allogeneic transplants and autologous transplants. The allogeneic transplants segment has been leading this market and is expected to continue on the top over the next few years. Allogeneic transplants are of two types: Family related and unrelated transplant.

The increasing number of donors and post-transplant survival rates are likely to drive this segment in the years to come. The autologous segment, on the other hand, is anticipated to grow steadily over the forthcoming years on account of the usage of autologous transplants as the standard of care for multiple myeloma (MM) patients.

Regen Biopharma Inc., Escape Therapeutics Inc., Cryo-Save AG, Lonza Group Ltd., Pluristem Therapeutics Inc., China Cord Blood Corp., CBR Systems Inc., and ViaCord Inc. are the leading players operating in the global market for hematopoietic stem cell transplantation (HSCT).

Section 01 Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Section 02 Assumptions and Research Methodology 
2.1. Assumptions and Acronyms Used
2.3. Research Methodology

Section 03 Executive Summary
3.1. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Snapshot

Section 04 Market Overview
4.1. Transplant Overview
4.2. Key Industry Developments
4.3. Key Market Indicators

Section 05 Market Dynamics
5.1. Opportunity Analysis
5.2. Drivers and Restraints Snapshot Analysis
5.3. Drivers
       5.3.1. Rising prevalence of hematological disorders
       5.3.2. Increase in success rates of transplantation
       5.3.3. Favorable reimbursement policies & fervent funding
       5.3.4. Increasing patient awareness and health care expenditure
       5.3.5. Increase aging population 
5.4. Restraints
       5.4.1. Insufficient allogeneic donors
       5.4.2. Potential complications and side effects of HSC transplant
       5.4.3. High cost of transplants
       5.4.4. Drug development may impact HSC transplant rates
5.5. Porters Analysis

Section 06 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis, by Transplant Type
6.1. Key Findings
6.2. Introduction
6.3. Market Forecast by Transplant Type
       6.3.1. Autologous
               6.3.1.1 Family Related
               6.3.1.2 Unrelated
       6.3.2. Allogeneic
6.4. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Attractiveness Analysis, by Transplant Type
6.3. Key Trends

Section 07 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis, by Disease Indication
7.1. Key Findings
7.2. Introduction
7.3. Market Forecast by Indication
       7.3.1. Lymphoproliferative disorders
       7.3.2. Leukemia
       7.3.3. Non-malignant Disorders
7.4. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Attractiveness Analysis, by Disease Indication

Section 08 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis, by Application
8.1. Key Findings
8.2. Introduction
8.3. Market Forecast by Application
       8.3.1. Peripheral Blood Stem Cells Transplant (PBSCT)
       8.3.2. Bone Marrow Transplant (BMT)
       8.3.3. Cord Blood Transplant (CBT)
8.4. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Attractiveness Analysis, by Application
8.5. Key Trends

Section 9 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis, by Region 
9.1. Global Market Scenario, by Country
9.2. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Value Share Analysis and Market Attractiveness Analysis, by Region
       9.2.1. North America
       9.2.2. Europe
       9.2.3. Asia Pacific
       9.2.4. Latin America
       9.2.5. Middle East & Africa

Section 10 North America Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. North America HSCT Market Value Share Analysis, by Transplant Type
10.4. North America HSCT Market Forecast, by Transplant Type
10.5. North America HSCT Market Value Share Analysis, by Transplant Type
10.6. North America HSCT Market Forecast, by Disease Indication
10.7. North America HSCT Market Value Share Analysis, by Disease Indication
10.8. North America HSCT Market Forecast, by Disease Indication
10.9. North America HSCT Market Value Share Analysis, by Application
10.10. North America HSCT Market Forecast, by Application
10.11. North America HSCT Market Forecast, by Application
10.12. North America HSCT Market Value Share Analysis, by Country
10.13. North America HSCT Market Forecast, by Country
10.14. North America HSCT Market Forecast, by Country
10.15. North America HSCT Market Attractiveness Analysis
10.16. Key Trends

Section 11 Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Value Share Analysis, by Transplant Type
11.4. Europe HSCT Market Forecast, by Transplant Type
11.5. Europe HSCT Market Value Share Analysis, by Transplant Type
11.6. Europe HSCT Market Forecast, by Disease Indication
11.7. Europe HSCT Market Value Share Analysis, by Disease Indication
11.8. Europe HSCT Market Forecast, by Disease Indication
11.9. Europe HSCT Market Value Share Analysis, by Application
11.10. Europe HSCT Market Forecast, by Application
11.11. Europe HSCT Market Forecast, by Application
11.12. Europe HSCT Market Value Share Analysis, by Country
11.13. Europe HSCT Market Forecast, by Country
11.14. Europe HSCT Market Forecast, by Country
11.15. Europe HSCT Market Attractiveness Analysis
11.16. Key Trends

Section 12 APAC Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. APAC HSCT Market Value Share Analysis, by Transplant Type
12.4. APAC HSCT market Forecast, by Transplant Type
12.5. APAC HSCT Market Value Share Analysis, by Transplant Type
12.6. APAC HSCT Market Value Share Analysis, by Disease Indication
12.7. APAC HSCTMarket Value Share Analysis, by Disease Indication
12.8. APAC HSCTMarket Forecast, by Disease Indication
12.9. APAC Hematopoietic Stem Cell Transplantation (HSCT) Market Value Share Analysis, by Application
12.10. APAC HSCT Market Forecast, by Application
12.11. APAC HSCT Market Forecast, by Application
12.12. APAC HSCT Market Value Share Analysis, by Country
12.13. APAC HSCT Market Forecast, by Country
12.14. APAC HSCT Market Forecast, by Country
12.15. APAC HSCT Market Attractiveness Analysis
12.16. Market Trends

Section 13 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Latin America HSCT Market Value Share Analysis, by Transplant Type
13.4. Latin America HSCT market Forecast, by Transplant Type
13.5. Latin America HSCT Market Value Share Analysis, by Transplant Type
13.6. Latin America HSCT Market Value Share Analysis, by Disease Indication
13.7. Latin America HSCT Market Value Share Analysis, by Disease Indication
13.8. Latin America HSCT Market Forecast, by Disease Indication
13.9. Latin America HSCT Market Value Share Analysis, by Application
13.10. Latin America HSCT Market Forecast, by Application
13.11. Latin America HSCT Market Forecast, by Application
13.12. Latin America HSCTMarket Value Share Analysis, by Country
13.13. Latin America HSCT Market Forecast, by Country
13.14. Latin America HSCT Market Forecast, by Country
13.15. Latin America HSCTMarket Attractiveness Analysis
13.16. Market Trends

Section 14 Middle East & Africa (MEA) Hematopoietic Stem Cell Transplantation (HSCT) Market Analysis
14.1. Key Findings
14.2. Market Overview
14.3. MEA HSCT Market Value Share Analysis, by Transplant Type
14.4. MEA HSCT Market Forecast, by Transplant Type
14.5. MEA HSCT Market Value Share Analysis, by Transplant Type
14.6. MEA HSCT Market Value Share Analysis, by Disease Indication
14.7. MEA HSCT Market Value Share Analysis, by Disease Indication
14.8. MEA HSCT Market Forecast, by Disease Indication
14.9. MEA HSCT Market Value Share Analysis, by Application
14.10. MEA HSCT Market Forecast, by Application
14.11. MEA HSCT Market Forecast, by Application
14.12. MEA HSCT Market Value Share Analysis, by Country
14.13. MEA HSCTMarket Forecast, by Country
14.14. MEA HSCT Market Forecast, by Country
14.15. MEA HSCT Market Attractiveness Analysis
14.16. Market Trends

Section 15 Competition Landscape
15.1. Company Profiles
15.1. Regen Biopharma, Inc. 
       15.1.1. Company Details
       15.1.2. Business Overview
       15.1.3. Financial Overview
       15.1.4. Strategic Overview
       15.1.5. SWOT Analysis
15.2. Escape Therapeutics, Inc. 
       15.2.1. Company Details
       15.2.2. Business Overview
       15.2.3. Financial Overview
       15.2.4. Strategic Overview
       15.2.5. SWOT Analysis
15.3. Cryo-Save AG 
              15.3.1. Company Details
       15.3.2. Business Overview
       15.3.3. Financial Overview
       15.3.4. Strategic Overview
       15.3.5. SWOT Analysis
15.4. Lonza Group Ltd 
       15.4.1. Company Details
       15.4.2. Business Overview
       15.4.3. Financial Overview
       15.4.4. Strategic Overview
       15.4.5. SWOT Analysis
15.5. Pluristem Therapeutics Inc. 
       15.5.1. Company Details
       15.5.2. Business Overview
       15.5.3. Financial Overview
       15.5.4. Strategic Overview
       15.5.5. SWOT Analysis
15.6. China Cord Blood Corporation. 
       15.6.1. Company Details
       15.6.2. Business Overview
       15.6.3. Financial Overview
       15.6.4. Strategic Overview
       15.6.5. SWOT Analysis
15.7. CBR Systems, Inc. 
       15.7.1. Company Details
       15.7.2. Business Overview
       15.7.3. Financial Overview
       15.7.4. Strategic Overview
       15.7.5. SWOT Analysis
15.8. ViaCord Inc. 
       15.8.1. Company Details
       15.8.2. Business Overview
       15.8.3. Financial Overview
       15.8.4. Strategic Overview
       15.8.5. SWOT Analysis

List of Figures

Figure 01: Global Hematopoietic Stem Cell Transplantation (HSCT) market Value Share Analysis, by Transplant Type, 2016 and 2024
Figure 02: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allogeneic, 2016-2025
Figure 03: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Autologous, 2016-2025
Figure 04: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allogeneic, 2016-2025
Figure 05: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Autologous, 2016-2025
Figure 06: Global HSCT Market Attractiveness Analysis, by Transplant Type
Figure 07: Global HSCT market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 08: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lymphoproliferative disorders, 2015-2025
Figure 09: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Leukemia, 2015-2025
Figure 10: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015-2025
Figure 11: Global HSCT market Attractiveness Analysis, by Disease Indication
Figure 12: Global HSCT market Value Share Analysis, by Application, 2016 and 2024
Figure 13: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025 (Bone marrow transplant (BMT))
Figure 14: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025 (Peripheral blood stem cell transplant)
Figure 15: Global HSCT Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2025 (Cord blood transplant)
Figure 16: Hematopoietic Stem Cell Transplantation (HSCT) market Attractiveness Analysis, by source
Figure 17: Global HSCT market Value Share Analysis, by Region, 2016 and 2024
Figure 18: Global HSCT market Attractiveness Analysis, by Region
Figure 19: North America Hematopoietic Stem Cell Transplantation (HSCT) Market Size (US$ Mn) and Volume (Units) 2016-2025
Figure 20: North America HSCT Market Attractiveness Analysis, by Country
Figure 21: North America HSCT Market Value Share Analysis, by Transplant Type, 2016 and 2024
Figure 22: North America HSCT Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 23: North America HSCT Market Value Share Analysis, by Application, 2016 and 2024
Figure 24: North America HSCT Market Value Share Analysis, by Country, 2016 and 2024
Figure 25: North America HSCT Market Attractiveness Analysis, by Transplant Type
Figure 26: North America HSCT Market Attractiveness Analysis, by Disease Indication
Figure 27: North America HSCT Market Attractiveness Analysis, by Application
Figure 28: Europe Hematopoietic Stem Cell Transplantation (HSCT) Market Size (US$ Mn) and Volume (Units) 2016-2025
Figure 29: Europe HSCT Market Attractiveness Analysis, by Country
Figure 30: Europe HSCT Market Value Share Analysis, by Transplant Type, 2016 and 2025
Figure 31: Europe HSCT Market Value Share Analysis, by Disease Indication, 2016 and 2025
Figure 32: Europe HSCT Market Value Share Analysis, by Application, 2016 and 2025
Figure 33: Europe HSCT Market Value Share Analysis, by Country, 2016 and 2025
Figure 34: Europe HSCT Market Attractiveness Analysis, by Transplant Type
Figure 35: Europe HSCT Market Attractiveness Analysis, by Disease Indication
Figure 36: Europe HSCT Market Attractiveness Analysis, by Application
Figure 37: Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Size (US$ Mn) and Volume (Units) 2016-2025
Figure 38: Asia Pacific HSCT Market Attractiveness Analysis, by Country
Figure 39: Asia Pacific HSCT Market Value Share Analysis, by Transplant Type, 2016 and 2025
Figure 40: Asia Pacific HSCT Market Value Share Analysis, by Disease Indication, 2016 and 2025
Figure 41: Asia Pacific HSCT Market Value Share Analysis, by Application, 2016 and 2024
Figure 42: Asia Pacific HSCT Market Value Share Analysis, by Country, 2016 and 2024
Figure 43: Asia Pacific HSCT Market Attractiveness Analysis, by Transplant Type
Figure 44: Asia Pacific HSCT Market Attractiveness Analysis, by Disease Indication
Figure 45: Asia Pacific HSCT Market Attractiveness Analysis, by Application
Figure 46: Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Size (US$ Mn) and Volume (Units) 2016-2025
Figure 47: Latin America HSCT Market Attractiveness Analysis, by Country
Figure 48: Latin America HSCT Market Value Share Analysis, by Transplant Type, 2016 and 2025
Figure 49: Latin America HSCT Market Value Share Analysis, by Disease Indication, 2016 and 2025
Figure 50: Latin America HSCT Market Value Share Analysis, by Application, 2016 and 2024
Figure 51: Latin America HSCTMarket Value Share Analysis, by Country, 2016 and 2024
Figure 52: Latin America HSCT Market Attractiveness Analysis, by Transplant Type
Figure 53: Latin America HSCT Market Attractiveness Analysis, by Disease Indication
Figure 54: Latin America HSCT Market Attractiveness Analysis, by Application
Figure 55: Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) Market Size (US$ Mn) and Volume (Units) 2016-2025
Figure 56: Middle East & Africa HSCTMarket Value Share Analysis, by Transplant Type, 2016 and 2025
Figure 57: Middle East & Africa HSCT Market Value Share Analysis, by Disease Indication, 2016 and 2025
Figure 58: Middle East & Africa HSCT Market Value Share Analysis, by Application, 2016 and 2024
Figure 59: Middle East & Africa HSCT Market Value Share Analysis, by Country, 2016 and 2024
Figure 60: Middle East & Africa HSCT Market Attractiveness Analysis, by Transplant Type
Figure 61: Middle East & Africa HSCT Market Attractiveness Analysis, by Disease Indication
Figure 62: Latin America Hematopoietic Stem Cell Transplantation (HSCT) Market Attractiveness Analysis, by Application

List of Table

Table 01: Global Hematopoietic Stem Cell Transplantation (HSCT) market size (US$ Mn) Forecast, by Transplant Type, 2015-2025
Table 02: Global HSCT market Volume (Units) Forecast, by Transplant Type, 2015-2025
Table 04: Global HSCT market Volume (Units) Forecast, by Disease Indication, 2016-2025
Table 05: Global HSCT Market Size (US$ Mn) Forecast, by Application, 2016-2025
Table 06: Global HSCT market Volume (Units) Forecast, by Application, 2016-2025
Table 07: Global HSCTMarket Size (US$ Mn)) Forecast, by Region, 2015-2025
Table 08: Global HSCT Market Volume (Units) Forecast, by Region, 2015-2025
Table 09: North America Hematopoietic Stem Cell Transplantation (HSCT) market size (US$ Mn) Forecast, by Transplant Type, 2015-2025
Table 10: North America HSCT market Volume (Units) Forecast, by Transplant Type, 2015-2025
Table 11: North America HSCT market Size (US$ Mn) Forecast, by Disease Indication, 2016-2025
Table 12: North America HSCT market Volume (Units) Forecast, by Disease Indication, 2016-2025
Table 13: North America HSCT market Size (US$ Mn) Forecast, by Application, 2016-2025
Table 14: North America HSCT market Volume (Units) Forecast, by Application, 2016-2025
Table 15: North America HSCT Market Size (US$ Mn) Forecast, by Country, 2015-2025
Table 16: North America HSCT Market Volume (Units) Forecast, by Country, 2015-2025
Table 17: Europe Hematopoietic Stem Cell Transplantation (HSCT) market size (US$ Mn) Forecast, by Transplant Type, 2015-2025
Table 18: Europe HSCT market Volume (Units) Forecast, by Transplant Type, 2015-2025
Table 19: Europe HSCT market Size (US$ Mn) Forecast, by Disease Indication, 2016-2025
Table 20: Europe HSCT Market Volume (Units) Forecast, by Disease Indication, 2016-2025
Table 21: Europe HSCT market Size (US$ Mn) Forecast, by Application, 2016-2025
Table 22: Europe HSCT market Volume (Units) Forecast, by Application, 2016-2025
Table 23: Europe HSCT Market Size (US$ Mn) Forecast, by Country, 2015-2025
Table 24: Europe HSCT Market Volume (Units) Forecast, by Country, 2015-2025
Table 25: Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) market size (US$ Mn) Forecast, by Transplant Type, 2015-2025
Table 26: Asia Pacific HSCT Market Volume (Units) Forecast, by Transplant Type, 2015-2025
Table 27: Asia Pacific HSCT market Size (US$ Mn) Forecast, by Disease Indication, 2016-2025
Table 28: Asia Pacific HSCT market Volume (Units) Forecast, by Disease Indication, 2016-2025
Table 29: Asia Pacific HSCT market Size (US$ Mn) Forecast, by Application, 2016-2025
Table 30: Asia Pacific HSCTmarket Volume (Units) Forecast, by Application, 2016-2025
Table 31: Asia Pacific HSCT Market Size (US$ Mn) Forecast, by Country, 2015-2025
Table 32: Asia Pacific HSCT Market Volume (Units) Forecast, by Country, 2015-2025
Table 33: Latin America Hematopoietic Stem Cell Transplantation (HSCT) market size (US$ Mn) Forecast, by Transplant Type, 2015-2025
Table 34: Middle East & Africa HSCT market Volume (Units) Forecast, by Transplant Type, 2015-2025
Table 35: Latin America HSCT market Size (US$ Mn) Forecast, by Disease Indication, 2016-2025
Table 36: Latin America HSCT market Volume (Units) Forecast, by Disease Indication, 2016-2025
Table 37: Latin America HSCT market Size (US$ Mn) Forecast, by Application, 2016-2025
Table 38: Latin America HSCT market Volume (Units) Forecast, by Application, 2016-2025
Table 39: Latin America HSCT Market Size (US$ Mn) Forecast, by Country, 2015-2025
Table 40: Latin America HSCT Market Volume (Units) Forecast, by Country, 2015-2025
Table 41: Middle East & Africa Hematopoietic Stem Cell Transplantation (HSCT) market size (US$ Mn) Forecast, by Transplant Type, 2015-2025
Table 42: Middle East & Africa HSCT market Volume (Units) Forecast, by Transplant Type, 2015-2025
Table 43: Middle East & Africa HSCT market Size (US$ Mn) Forecast, by Disease Indication, 2016-2025
Table 44: Middle East & Africa HSCT market Volume (Units) Forecast, by Disease Indication, 2016-2025
Table 45: Middle East & Africa HSCT market Size (US$ Mn) Forecast, by Application, 2016-2025
Table 46: Middle East & Africa HSCTmarket Volume (Units) Forecast, by Application, 2016-2025
Table 47: Middle East & Africa HSCT Market Size (US$ Mn) Forecast, by Country, 2015-2025
Table 48: Middle East & Africa HSCT Market Volume (Units) Forecast, by Country, 2015-2025

 

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Overview

This report on Hematopoietic Stem Cell Transplantation (HSCT) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of HSCT as well as new entrants planning to enter this market.

This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global HSCT market with respect to the leading market segments based on transplants types, disease indication, applications and geographies.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global hematopoietic stem cell transplantation (HSCT) market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different transplants/disease indication/applications/geographies. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Segmentation

The global hematopoietic stem cell transplantation (HSCT) market is divided into: by transplant type, by disease indication, by application and by geography. Transplant type segment of HSCT market was divided into autologous transplant and allogeneic transplant. While allogeneic transplant was further segmented into family related and unrelated transplant. On the basis of disease indication the market was divided into lymphoproliferative disorders, leukemia, non-malignant disorders. On the basis of application the hematopoietic stem cell transplantation (HSCT) market is divided as peripheral blood stem cells transplant (PBSCT), bone marrow transplant (BMT), and cord blood transplant (CBT).

Geographically, the hematopoietic stem cell transplantation (HSCT) market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for HSCT market has been further categorized into major transplant type, disease indication, and application segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2017 to 2025, along with the compound annual growth rate (CAGR %) from 2017 to 2025) are provided for all segments, considering 2016 as the base year. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2015 to 2025 along with CAGR % from 2016 to 2025 are provided for all the regions and nations considering 2016 as the base year.

Companies Mentioned in the Report

The report profiles key manufacturers in the hematopoietic stem cell transplantation (HSCT) Market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include Regen Biopharma, Inc., Escape Therapeutics, Inc., Lonza Group Ltd., and Pluristem Therapeutics Inc.

The global hematopoietic stem cell transplantation (HSCT) Market has been segmented as follows:

By Transplant Type

  • Allogeneic
    • Family Related
    • Unrelated
  • Autologous

By Disease Indication

  • Lymphoproliferative disorders
  • Leukemia
  • Non-malignant Disorders       

By Application

  • Peripheral Blood Stem Cells Transplant (PBSCT)
  • Bone Marrow Transplant (BMT)
  • Cord Blood Transplant (CBT)

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa


 
 
Back To Top